TrialThe New England journal of medicine2026
Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
Paolo A Ascierto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
TrialThe New England journal of medicine2026
Paolo A Ascierto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.